SCHEMBL29480651

SCHEMBL29480651

CS(=O)(=O)CCC(C#N)c1ccc(-n2cc(-c3ccnc(N)c3[N+](=O)[O-])cn2)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22736320 0.88 GRM4 (0.32) —
SCHEMBL29567465 0.88 GRM4 (0.32) —
SCHEMBL22736319 0.88 — —
SCHEMBL22735968 0.85 — —
SCHEMBL29480751 0.85 — —
SCHEMBL29480652 0.83 EGLN1 (0.34) —
SCHEMBL22735954 0.83 EGLN1 (0.34) —
SCHEMBL29480704 0.83 — —
SCHEMBL22716782 0.79 JAK2 (0.36) —
SCHEMBL29480498 0.79 JAK2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114174294-B Novel compounds for inhibiting JANUS kinase 1 人类制药有限公司 2024-10-25 — — CN disclosed
EP-3976612-A1 NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 MANKIND PHARMA LTD (IN) 2022-04-06 — — EP disclosed
CN-114174294-A Novel compounds for inhibiting JANUS kinase 1 人类制药有限公司 2022-03-11 — — CN disclosed
Send feedback